Home › Funds › Sanofi › MPLT

Sanofi position in MPLT

MAPLIGHT THERAPEUTICS INC · Health Care

Sanofi reported holding 912,041 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.48% of its reported portfolio and ranking #13 among its reported holdings. Sanofi has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)912.04K sh
Reported value held$9.29M
Portfolio Weight1.48%
First reportedQ4 2025
Last changeHold
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How Sanofi's MPLT position evolved

Sanofi first disclosed a stake in MPLT in Q4 2025 at 912,041 shares (US$16.0M). The position peaked in Q2 2026 at 912,041 shares, worth US$32.7M. Across 4 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 912,041 shares valued at US$9.3M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 912.04K $16.02M New
Q1 2026 912.04K $18.54M Hold
Q2 2026 912.04K $32.69M Hold
Q3 2026 912.04K $9.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MPLT and 13F data

MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 120 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MPLT

All MPLT fund holders →

FAQ

How long has Sanofi held MPLT?

Sanofi has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Sanofi's current position in MPLT?

As of Q3 2026, Sanofi holds 912.04K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $9.29M, representing 1.48% of its reported portfolio and ranking #13.

Has Sanofi been buying or selling MPLT?

In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in MPLT. The position peaked in Q2 2026 at 912.04K shares.

Which other funds hold MPLT?

Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 120 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.